Bioresorbable Polymers Market by Product Type (Polycaprolactone, Polyglycolic Acid, Polylactic Acid), Application (Drug Delivery, Orthopedics) - Global Forecast 2024-2030

Bioresorbable Polymers Market by Product Type (Polycaprolactone, Polyglycolic Acid, Polylactic Acid), Application (Drug Delivery, Orthopedics) - Global Forecast 2024-2030

The Bioresorbable Polymers Market size was estimated at USD 905.90 million in 2023 and expected to reach USD 998.48 million in 2024, at a CAGR 10.47% to reach USD 1,819.30 million by 2030.

Global Bioresorbable Polymers MarketBioresorbable polymers are biodegradable, biocompatible, and noncytotoxic materials that are safely absorbed by the body. The physical and degradation properties of bioresorbable polymers allow these polymers to be used for various applications such as orthopedic fixation, vascular stents, tissue engineering, and controlled drug delivery. The usage of bioresorbable polymers is significantly growing for various clinical applications, including bone implants, sutures, and drug delivery devices. Additionally, the worldwide increasing prevalence of orthopedic disorders, including arthritis, osteoarthritis, and rheumatoid arthritis, expanded the need for bioresorbable polymers for fracture fixation in orthopedic surgery or soft-tissue fixation. Furthermore, bioresorbable materials are used to create micro-scale medical devices and manufactured from various types of natural or synthetic polymers, including thermoplastic polyurethane and metals such as magnesium. However, the availability of less expensive and conventional bioresorbable polymers is hampering the growth of the bioresorbable polymer market. The technological advances in orthopedic implants and surgical devices are creating opportunities for the market.Regional InsightsThe U.S. has a developed pharmaceutical industry owing to the highest spending in the healthcare sector and the contribution of pharmaceutical manufacturers to the growth of the market across the North American region. Furthermore, the growing prevalence of arthritis in countries such as the U.S., the UK, China, and India expanded the need for bioresorbable polymers. Furthermore, pharmaceutical research and development (R&D) activities are significantly growing owing to government funding, a huge patient population, low costs, and the availability of an R&D workforce. Additionally, South Korea’s government has invested USD 693 million into the pharmaceutical industry to enhance R&D for new drugs. The African Development Fund invested USD 6 million in developing the pharmaceutical sector in Southern and Eastern Africa, subsequently expanding the market scope in the African region. In addtion, the pharmaceutical industry is expanding in the United Arab Emirates (UAE) and Saudi Arabia owing to ongoing improvements and government investments in the healthcare sector, assisting in the market growth in the Middle East & Africa region.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Bioresorbable Polymers Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Bioresorbable Polymers Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Bioresorbable Polymers Market, highlighting leading vendors and their innovative profiles. These include 3D Biotek LLC, Acuro Organics Limited, Aduro Biopolymers LP, Advanced Polymer Materials Inc., Anhui Jumei Biological Technology Co., Ltd., Ashland Inc., Avantium N.V., BMG Incorporated, CD Bioparticles, Celares GmbH, ChitoLytic, Corbion NV, Evonik Industries AG, Foster Corporation, Futerro Group, Galatea Surgical, Inc., Gebrüder Martin GmbH & Co. KG, Goodfellow Cambridge Ltd., Huizhou Foryou Medical Devices Co., Ltd., Koninklijke DSM N.V., MAST Biosurgery, MCG BioComposites, LLC, Merck KGaA, Mitsui & Co., Ltd., Musashino Chemical Laboratory, Ltd., Nanjing Jiayi Sunway Chemical Co., Ltd., Nanosoft Polymers, NatureWorks LLC, Nomisma Healthcare Pvt. Ltd., Otto Chemie Pvt. Ltd., PBI Performance Products, Inc., Plastics New Zealand, Poly-Med Incorporated, PolyClean Technologies, Inc., PolyNovo Limited, Polysciences, Inc., Putnam Plastics, QINGDAO SOCO NEW MATERIAL CO., LTD., REVA Medical, LLC, Rivika Bio Industries Pvt. Ltd., SEQENS SAS, Solanyl Biopolymers Inc., SpecialChem S.A., Stahl Holdings B.V., Stepan Company, Torise Biomaterials Co.,Ltd., UBQ Materials Ltd., Univar Solutions Inc., Vibha Ecopac Pvt Ltd., and Zeus Industrial Products, Inc..

Market Segmentation & Coverage



This research report categorizes the Bioresorbable Polymers Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product Type
Polycaprolactone
Polyglycolic Acid
Polylactic Acid
Polysaccharides
Proteins
Application
Drug Delivery
Oral
Parenteral
Orthopedics
Hip
Knee
Spine
Trauma
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Bioresorbable Polymers Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Bioresorbable Polymers Market?
3. What are the technology trends and regulatory frameworks in the Bioresorbable Polymers Market?
4. What is the market share of the leading vendors in the Bioresorbable Polymers Market?
5. Which modes and strategic moves are suitable for entering the Bioresorbable Polymers Market?

Note: PDF & Excel + Online Access - 1 Year